Physical function as assessed by the Liver Frailty Index remains stable over time in patients with hepatocellular carcinoma treated with locoregional therapies.
Madeleine D Hu, Sy Han Chiou, Molly Delk, Cynthia Fenton, Jennifer C Lai, Michael Li
{"title":"Physical function as assessed by the Liver Frailty Index remains stable over time in patients with hepatocellular carcinoma treated with locoregional therapies.","authors":"Madeleine D Hu, Sy Han Chiou, Molly Delk, Cynthia Fenton, Jennifer C Lai, Michael Li","doi":"10.14309/ctg.0000000000000854","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>It is unknown how frailty evolves over time in patients with hepatocellular carcinoma (HCC) who are treated with locoregional therapies (LRTs).</p><p><strong>Methods: </strong>We conducted a retrospective study of LRT-treated HCC patients with Liver Frailty Index (LFI) assessments. Linear mixed effects modeling was used to assess the impact of time (modeled linearly per month) and other variables on LFI.</p><p><strong>Results: </strong>Of 201 patients enrolled, median baseline LFI was 3.54. LFI did not change significantly over time from study entry (p=0.93).</p><p><strong>Conclusions: </strong>In our study, LFI remained stable over time after LRT, suggesting that LRT is generally well-tolerated.</p>","PeriodicalId":10278,"journal":{"name":"Clinical and Translational Gastroenterology","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14309/ctg.0000000000000854","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: It is unknown how frailty evolves over time in patients with hepatocellular carcinoma (HCC) who are treated with locoregional therapies (LRTs).
Methods: We conducted a retrospective study of LRT-treated HCC patients with Liver Frailty Index (LFI) assessments. Linear mixed effects modeling was used to assess the impact of time (modeled linearly per month) and other variables on LFI.
Results: Of 201 patients enrolled, median baseline LFI was 3.54. LFI did not change significantly over time from study entry (p=0.93).
Conclusions: In our study, LFI remained stable over time after LRT, suggesting that LRT is generally well-tolerated.
期刊介绍:
Clinical and Translational Gastroenterology (CTG), published on behalf of the American College of Gastroenterology (ACG), is a peer-reviewed open access online journal dedicated to innovative clinical work in the field of gastroenterology and hepatology. CTG hopes to fulfill an unmet need for clinicians and scientists by welcoming novel cohort studies, early-phase clinical trials, qualitative and quantitative epidemiologic research, hypothesis-generating research, studies of novel mechanisms and methodologies including public health interventions, and integration of approaches across organs and disciplines. CTG also welcomes hypothesis-generating small studies, methods papers, and translational research with clear applications to human physiology or disease.
Colon and small bowel
Endoscopy and novel diagnostics
Esophagus
Functional GI disorders
Immunology of the GI tract
Microbiology of the GI tract
Inflammatory bowel disease
Pancreas and biliary tract
Liver
Pathology
Pediatrics
Preventative medicine
Nutrition/obesity
Stomach.